In Vivo Imaging of Transplanted Islets with Cu-64-DO3A-VS-Cys(40)-Exendin-4 by Targeting GLP-1 Receptor

作者：Wu Zhanhong; Todorov Ivan; Li Lin; Bading James R; Li Zibo; Nair Indu; Ishiyama Kohei; Cocher David; Conti Peter E; Fraser Scott E; Shively John E; Kandeel Fouad^*

来源：Bioconjugate Chemistry, 2011, 22(8): 1587-1594.

DOI：10.1021/bc200132t

Glucagon-like peptide 1 receptor (GLP-1R) is highly expressed in pancreatic islets, especially on beta-cells. Therefore, a properly labeled ligand that binds to GLP-1R could be used for in vivo pancreatic islet imaging. Because native GLP-1 is degraded rapidly by dipeptidyl peptidase-IV (DPP-IV), a more stable agonist of GLP-1 such as Exendin-4 is a preferred imaging agent. In this study, DO3A-VS-Cys(40)-Exendin-4 was prepared through the conjugation of DO3A-VS with Cys(40)-Exendin-4. The in vitro binding affinity of DO3A-VS-Cys(40)-Exendin-4 was evaluated in INS-1 cells, which overexpress GLP-1R. After Cu-64 labeling, biodistribution studies and microPET imaging of Cu-64-DO3A-VS-Cys(40)-Exendin-4 were performed on both subcutaneous INS-1 tumors and islet transplantation models. The subcutaneous INS-1 tumor was dearly visualized with microPET imaging after the injection of Cu-64-DO3A-VS-Cys(40)-Exendin-4. GLP-1R positive organs, such as pancreas and lung, showed high uptake. Tumor uptake was saturable, reduced dramatically by a 20-fold excess of unlabeled Exendin-4. In the intraportal islet transplantation models, Cu-64-DO3A-VS-Cys(40)-Exendin-4 demonstrated almost two times higher uptake compared with normal mice. Cu-64-DO3A-VS-Cys(40)-Exendin-4 demonstrated persistent and specific uptake in the mouse pancreas, the subcutaneous insulinoma mouse model, and the intraportal human islet transplantation mouse model. This novel PET probe may be suitable for in vivo pancreatic islets imaging in the human.

• 出版日期2011-8